Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 18.00
Ask: 18.50
Change: 5.50 (43.14%)
Spread: 0.50 (2.778%)
Open: 12.75
High: 18.25
Low: 17.00
Prev. Close: 12.75
INSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible loan agreement and drawdown

17 Jun 2022 10:30

RNS Number : 2889P
Insig AI Plc
17 June 2022
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

17 June 2022 

 

Insig AI plc

("Insig AI" or the "Company")

Convertible Loan Facility Agreement and drawdown

Insig AI plc (AIM: INSG), the data science and machine learning group, is pleased to announce that it has entered into a new convertible loan facility agreement with David Kyte, a long-term shareholder in the Company (the "Agreement"). The key terms are the same as those agreed with Richard Bernstein, non-executive chairman of the Company, announced on 4 May 2022, save that Mr Bernstein is providing a facility of £1 million and Mr Kyte a facility of £0.5 million.

The loan is unsecured and repayable on or before 31 December 2022. Interest will accrue from the date monies are drawn down under the facility at a rate of 5.0 per cent. per annum, repayable in full at the end of the term.

The loan is redeemable or convertible at the sole discretion of Mr Kyte, at the earlier of the completion of an equity placing by the Company raising not less than £2.0m gross proceeds and 31 December 2022.

If converted, the conversion price will be the higher of 35.0 pence per ordinary share of the Company and the prevailing share price at the date of conversion.

Cash drawn down under the Agreement will be in tranches as required by the Company. An initial tranche of £0,2 million has been drawn down by the Company.

A second tranche of £150,000 has today been drawn down on the convertible loan facility provided by Richard Bernstein, meaning a total of £0.4 million has now been drawn down under that facility agreement.

Colm McVeigh, Chief Executive of Insig AI, commented: "I am pleased that David, a long-term supporter of the Company, has approached us to add to our funding options. As we continue to strengthen and deepen our pipeline, this funding will provide further financial flexibility while we continue our discussions with prospects, customers and potential partners."

For further information, please visit www.insg.ai or contact:  

Insig AI plc

Colm McVeigh (CEO)

Via SEC Newgate

 

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold / Danny Phillips

 

+44 (0) 20 3829 5000

SEC Newgate (Financial PR)

Robin Tozer / Richard Bicknell

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBOKRURUNARR
Date   Source Headline
30th Sep 202212:13 pmRNSResult of Annual General Meeting & General Meeting
30th Sep 20227:00 amRNSContract win
26th Sep 20227:00 amRNSConvertible Loan Facility drawdown
20th Sep 20227:00 amRNSChange of Registered Office
12th Sep 20227:00 amRNSConvertible Loan Facility Agreement
9th Sep 20227:00 amRNSFinal Results, Posting of Report and Notice of GM
8th Sep 20227:00 amRNSNotice of AGM
30th Aug 20227:00 amRNSConvertible Loan Facility Agreement and Drawdown
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSConvertible Loan Facility Agreement drawdown
19th Jul 20227:00 amRNSDirectors' Disclosure
6th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 202210:30 amRNSConvertible loan agreement and drawdown
31st May 20227:00 amRNSData partnership and research agreement
5th May 20227:00 amRNSData share partnership agreement with Snowflake
4th May 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
28th Apr 20227:00 amRNSUpdate on agreement with CarVal Investors, L.P
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNSContract win, trading update and Board changes
11th Apr 20227:00 amRNSDirectorate Change
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSTrading and operations update
25th Feb 20227:00 amRNSFurther agreement with CarVal Investors, L.P.
7th Feb 20227:00 amRNSInsig AI selected for PwC Scale FinTech programme
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
6th Jan 20221:41 pmRNSDirector/PDMR Shareholding
30th Dec 20217:00 amRNSDirectorate change
23rd Dec 202112:55 pmRNSDirector/PDMR Shareholding
23rd Dec 20218:42 amRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSInterim Results
13th Dec 20217:00 amRNSContract win
10th Dec 20217:00 amRNSColm McVeigh appointment to the Board
19th Nov 202111:36 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSDirector/PDMR Shareholding
18th Nov 20217:00 amRNSAcquisition of FDB Systems Limited
15th Nov 20217:00 amRNSProof of concept signed with asset manager
10th Nov 20217:00 amRNSESG scoring solution delivered to CarVal Investors
10th Nov 20217:00 amRNSColm McVeigh appointed as Chief Commercial Officer
4th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSInsig AI Becomes a Sponsor of the UK's APPG on ESG
4th Oct 20217:00 amRNSRelease of Insig Portfolio 2.0
30th Sep 202111:10 amRNSResult of AGM
15th Sep 20217:00 amRNSLaunch of Insig ESG
17th Aug 20217:00 amRNSCarVal HY and IG product lines partnership
13th Aug 20217:30 amRNSDirectorate changes
23rd Jul 20217:00 amRNSInsig to support CarVal Clean CLO Product Line
20th Jul 20218:04 amRNSLicense win and ESG product developments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.